SCHEMBL7190880

SCHEMBL7190880

CSn1ccc(-c2ccc(Oc3ccccc3)cc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 6/20 0.55
KMT2A Q03164 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
TNK2 Q07912 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LTA4H P09960 3/20 0.41
TLR8 Q9NR97 1/20 0.41
BTK Q06187 1/20 0.39
TSHR P16473 1/20 0.39
CYP19A1 P11511 1/20 0.39
GSTP1 P09211 1/20 0.39
XDH P47989 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14797416 0.84 KMT2A (0.61) KMT2ANPC1RAB9AKDM4EALDH1A1
SCHEMBL27568071 0.77 SCN4A (0.61) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL1385879 0.74 SCN4A (0.55) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL27774356 0.72 CYP19A1 (0.54) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL29095278 0.71 SCN4A (0.48) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL3365533 0.71 SCN4A (0.69) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL1384820 0.71 SCN4A (1.00) SCN4ANPC1RAB9ACA1CA2
SCHEMBL27007450 0.71 SCN4A (0.55) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL7048807 0.71 SCN4A (0.51) SCN4AKMT2ANPC1RAB9ACA1
SCHEMBL28057077 0.71 SCN4A (0.51) SCN4AKMT2ANPC1RAB9ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6589997-B2 1-Phenylprop-2-en-1-one derivatives as wound healing, anticarcinogenic, antiarthritic, antitumor, antiproliferative, antiinflammatory or antimetastasis agents NORTH SHORE-LONG ISLAND JEWISH HEALTH SYSTEM 2003-07-08 US disclosed